Bio X Cell Revenue and Competitors
Estimated Revenue & Valuation
- Bio X Cell's estimated annual revenue is currently $8.1M per year.
- Bio X Cell's estimated revenue per employee is $155,000
Employee Data
- Bio X Cell has 52 Employees.
- Bio X Cell grew their employee count by 86% last year.
Bio X Cell's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
3 | Chief Human Resources Officer | Reveal Email/Phone |
4 | Chief Commercial Officer | Reveal Email/Phone |
5 | Director, Scientific Affairs | Reveal Email/Phone |
6 | Member Board Directors | Reveal Email/Phone |
7 | Director Contract Service Sales | Reveal Email/Phone |
8 | Director Marketing | Reveal Email/Phone |
9 | Software Engineering Manager | Reveal Email/Phone |
10 | Territory Sales Manager - Northeast | Reveal Email/Phone |
Bio X Cell Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 72 | 6% | N/A | N/A |
#2 | $8.1M | 52 | 86% | N/A | N/A |
#3 | $2.6M | 17 | 31% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $4.5M | 29 | -12% | N/A | N/A |
#6 | $1.4M | 9 | 29% | N/A | N/A |
#7 | $36.4M | 235 | -20% | N/A | N/A |
#8 | $0.6M | 4 | -56% | N/A | N/A |
#9 | $2M | 13 | 0% | N/A | N/A |
#10 | $8.5M | 55 | -34% | N/A | N/A |
What Is Bio X Cell?
For more than 20 years, scientists have trusted Bio X Cell as their go-to source for in vivo functional grade antibodies. We take this responsibility to heart and have always focused our efforts on one goal: producing the highest-quality antibodies with unmatched value.
keywords:N/AN/A
Total Funding
52
Number of Employees
$8.1M
Revenue (est)
86%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.8M | 52 | 24% | N/A |
#2 | $12.6M | 52 | 0% | N/A |
#3 | $12.9M | 53 | 6% | N/A |
#4 | $8.6M | 53 | 10% | N/A |
#5 | $15M | 54 | 10% | N/A |